Sen. Tom Cotton (R-Ark.) on Thursday criticized the Department of Justice’s (DOJ) decision to downgrade state-approved medical marijuana to a less dangerous drug. “Marijuana today is much more potent

The Department of Justice said it would immediately loosen restrictions on some marijuana products and move quickly ​to reclassify the drug as less dangerous, in one of the biggest changes to U.S. drug policy in decades.

The order places FDA-approved products containing marijuana and state-regulated medical marijuana products at a lower drug classification.

The U.S. government is easing some rules on medical marijuana, reclassifying it from a Schedule 1 to a Schedule 3 drug, a move that aligns federal guidance with many state laws,

The federal government is reclassifying medical marijuana, categorizing it as a drug with potential medical benefits and less potential for harm. While this doesn’t legalize marijuana nationally, it does open the door for further research into its effects.

Medical marijuana is moving from Schedule I status, reserved for the most dangerous drugs like heroin and LSD, to Schedule III, like testosterone and steroids, which are less strictly regulated.

Local medical marijuana manufacturer and retailer Terrapin is lauding the Trump Administration’s move to reclassify the product as a less-dangerous drug. On Thursday, United States Acting Attorney General Todd Blanche signed an order reclassifying state-licensed medical marijuana as a Schedule III drug.

Advocates for medical cannabis in Utah are thrilled with the Trump administration's order moving state-regulated products to a Schedule 3 drug